Day: January 8, 2024

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) — Citeline, a Norstella company providing robust data and expert business intelligence to the pharmaceutical industry, will offer exclusive access to insights from the 42^nd Annual J.P. Morgan Healthcare Conference (JPM) Jan. 8–11, 2024 in San Francisco.

JPM, the industry’s largest healthcare investment symposium, provides a detailed look at the state of the industry today and where it is headed in the coming year. This invite-only event brings together global industry leaders, emerging fast-growth companies, technology creators, and members of the investment community to discuss the latest market trends and innovations.

Citeline will provide daily updates and insights from JPM24. Those who register for updates will receive a top-level summary (via Scrip) and a detailed breakdown of what was announced in each company’s presentations (via Biomedtracker).

Key industry experts from Citeline attending JPM include analysts and reporters from Citeline’s Scrip and Biomedtracker publications. Further Citeline coverage will also be provided by journalists from Medtech Insight.

Following the conference, Citeline will host a webinar with a panel of industry experts to discuss key JPM takeaways with an outlook for 2024. The webinar will take place Feb. 6.

Sign up for access to Citeline’s JPM updates. For access to Scrip and Biomedtracker, visit Citeline.

About Citeline
Citeline, a Norstella company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth.

Citeline’s global teams of analysts, journalists, and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts, and more. For more information on one of the world’s most trusted health science partners, visit Citeline and follow on LinkedIn and X (formerly Twitter).

Citeline PR contact:
Diffusion PR for Citeline
citeline@diffusionpr.com
(213) 318-4500

GlobeNewswire Distribution ID 9013338

The Summit will bring together leaders from fields of art, heritage, media, museums, music, public policy and technology from over 90 countries to explore our changing relation to time

Organised with leading global partners including UNESCO, Economist Impact, Design Museum, Google, Solomon R. Guggenheim Museum and Foundation, and the Recording Academy^®

From left: Manal Ataya, Sultan Sooud Al Qassemi, Maya Allison, Fiammetta Rocco and Dr. Rafal Niemojewski, Culture Summit 2022. Courtesy DCT Abu Dhabi

ABU DHABI, United Arab Emirates, Jan. 08, 2024 (GLOBE NEWSWIRE) — The Department of Culture and Tourism – Abu Dhabi (DCT Abu Dhabi) has announced the new dates for the sixth edition of its leading global forum, Culture Summit Abu Dhabi. This renowned thought leadership gathering will return to Manarat Al Saadiyat in Abu Dhabi from 3 to 5 March 2024.

Held under the theme A Matter of Time, this edition will gather an exceptional collection of thought leaders from the various fields such as art, heritage, media, music, museums, public policy, and technology. They will investigate how the role that culture – which so often holds together past, present, future – could play in helping us navigate this moment of inflection in the way we relate to the notion of time. The sessions will shift away from ‘mechanical time’ – characteristic of our contemporary era – to a ‘new cultural time’, one that is realigned with the rhythm of human awareness and nature.

Each day, the Summit programme will follow a specific sub-theme to unpack how our relation to time is evolving, examine the challenges this evolution represents for the culture and creative sectors, and provide focused, functional solutions. The agenda will feature keynotes, plenary sessions, panel discussions, artist talks, case study workshops, creative conversations, policy sessions, cultural performances, and a visual art exhibition.

The event’s key global partners include UNESCO, Economist Impact, Design Museum, Google, Solomon R. Guggenheim Museum and Foundation, and the Recording Academy^®.

Additional Culture Summit Abu Dhabi partners include Anwar Gargash Diplomatic Academy, Arab World Institute, Berklee Abu Dhabi, Club de Madrid, Cultural Foundation, IFACCA, Image Nation Abu Dhabi, Louvre Abu Dhabi, NYUAD and World Cities Culture Forum, and Zayed National Museum, among others.

For more information, visit the Culture Summit Abu Dhabi website: https://www.culturesummitabudhabi.com

Culture Summit Abu Dhabi Press Kit, including imagery, is available here: https://rb.gy/1nbem

PRESS ENQUIRIES:
Anastasia Lander, Pelham Communications
anastasia@pelhamcommunications.com

About the Department of Culture and Tourism – Abu Dhabi
The Department of Culture and Tourism – Abu Dhabi (DCT Abu Dhabi) drives the sustainable growth of Abu Dhabi’s culture and tourism sectors, fuels economic progress and helps achieve Abu Dhabi’s wider global ambitions. By working in partnership with the organisations that define the emirate’s position as a leading international destination, DCT Abu Dhabi strives to unite the ecosystem around a shared vision of the emirate’s potential, coordinate effort and investment, deliver innovative solutions, and use the best tools, policies and systems to support the culture, creative and tourism industries.

DCT Abu Dhabi’s vision is defined by the emirate’s people, heritage and landscape. We work to enhance Abu Dhabi’s status as a place of authenticity, innovation, and unparalleled experiences, represented by its living traditions of hospitality, pioneering initiatives and creative thought.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/67e290ab-15a8-483b-a978-9520dbd25522

GlobeNewswire Distribution ID 9014155

Single SoC Supports One to 34 Billion-Parameter, Multi-Modal LLMs With Low Power Consumption, Enabling Generative AI for Edge Endpoint Devices

SANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced during CES that it is demonstrating multi-modal large language models (LLMs) running on its new N1 SoC series at a fraction of the power-per-inference of leading GPU solutions. Ambarella aims to bring generative AI—a transformative technology that first appeared in servers due to the large processing power required—to edge endpoint devices and on-premise hardware, across a wide range of applications such as video security analysis, robotics and a multitude of industrial applications.

Ambarella will initially be offering optimized generative AI processing capabilities on its mid to high-end SoCs, from the existing CV72 for on-device performance under 5W, through to the new N1 series for server-grade performance under 50W. Compared to GPUs and other AI accelerators, Ambarella provides complete SoC solutions that are up to 3x more power-efficient per generated token, while enabling immediate and cost-effective deployment in products.

“Generative AI networks are enabling new functions across our target application markets that were just not possible before,” said Les Kohn, CTO and co-founder of Ambarella. “All edge devices are about to get a lot smarter, with our N1 series of SoCs enabling world-class multi-modal LLM processing in a very attractive power/price envelope.”

“Virtually every edge application will get enhanced by generative AI in the next 18 months,” said Alexander Harrowell, Principal Analyst, Advanced Computing at Omdia. “When moving genAI workloads to the edge, the game becomes all about performance per watt and integration with the rest of the edge ecosystem, not just raw throughput.”

All of Ambarella’s AI SoCs are supported by the company’s new Cooper Developer Platform. Additionally, in order to reduce customers’ time-to-market, Ambarella has pre-ported and optimized popular LLMs, such as Llama-2, as well as the Large Language and Video Assistant (LLava) model running on N1 for multi-modal vision analysis of up to 32 camera sources. These pre-trained and fine-tuned models will be available for partners to download from the Cooper Model Garden.

For many real-world applications, visual input is a key modality, in addition to language, and Ambarella’s SoC architecture is natively well-suited to process video and AI simultaneously at very low power. Providing a full-function SoC enables the highly efficient processing of multi-modal LLMs while still performing all system functions, unlike a standalone AI accelerator.

Generative AI will be a step function for computer vision processing that brings context and scene understanding to a variety of devices, from security installations and autonomous robots to industrial applications. Examples of the on-device LLM and multi-modal processing enabled by this new Ambarella offering include: smart contextual searches of security footage; robots that can be controlled with natural language commands; and different AI helpers that can perform anything from code generation to text and image generation.

Most of these systems rely heavily on both camera and natural language understanding, and will benefit from on-device generative AI processing for speed and privacy, as well as a lower total cost of ownership. The local processing enabled by Ambarella’s solutions also perfectly suits application-specific LLMs, which are typically fine-tuned on the edge for each individual scenario; versus the classical server approach of using bigger and more power-hungry LLMs to cater to every use case.

Based on Ambarella’s powerful CV3-HD architecture, initially developed for autonomous driving applications, the N1 series of SoCs repurposes all this performance for running multi-modal LLMs in an extremely low power footprint. For example, the N1 SoC runs Llama2-13B with up to 25 output tokens per second in single-streaming mode at under 50W of power. Combined with the ease-of-integration of pre-ported models, this new solution can quickly help OEMs deploy generative AI into any power-sensitive application, from an on-premise AI box to a delivery robot.

Both the N1 SoC and a demonstration of its multi-modal LLM capabilities will be on display this week at the Ambarella exhibition during CES.

About Ambarella
Ambarella’s products are used in a wide variety of human vision and edge AI applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver/cabin monitoring, autonomous driving and robotics applications. Ambarella’s low-power systems-on-chip (SoCs) offer high-resolution video compression, advanced image and radar processing, and powerful deep neural network processing to enable intelligent perception, fusion and planning. For more information, please visit www.ambarella.com.

Ambarella Contacts

• Media contact: Eric Lawson, elawson@ambarella.com, +1 480-276-9572
• Investor contact: Louis Gerhardy, lgerhardy@ambarella.com, +1 408-636-2310
• Sales contact: https://www.ambarella.com/contact-us/

All brand names, product names, or trademarks belong to their respective holders. Ambarella reserves the right to alter product and service offerings, specifications, and pricing at any time without notice. © 2024 Ambarella. All rights reserved.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/10ee7319-3783-423b-b8f6-d3f6d219293b

GlobeNewswire Distribution ID 9013889

• Nasdaq European Markets welcomed 33 listings, including 7 initial public offerings (IPOs), raising a total of EUR 431 million risk capital and EUR 11.6 bn in secondary offerings
• Nasdaq celebrated its 130^th company to transfer from Nasdaq First North Growth Market to Main Market

STOCKHOLM, Sweden, Jan. 08, 2024 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today presented its yearly statistics for Nasdaq European markets. Despite the uncertainties in the wider global economy, the Nordic and Baltic regions maintained their position in capital markets in several key areas, including Sustainable Debt Market and SME listings. In total, the Nasdaq equity markets in Sweden, Denmark, Finland, Iceland and the Baltic countries welcomed 33 listings, including 7 initial public offerings (IPOs), raising a total of EUR 431 million risk capital (2022: EUR 0.76 bn) and EUR 11.6 bn in secondary offerings (2022: EUR 16.6 bn). With 19 listings, Nasdaq Stockholm also remained one of the most successful listings venues in Europe in 2023.

“Our European Market Services team has worked tirelessly to keep driving our technology leadership, marketplace excellence and strong commitment to sustainability to create a world class capital market offering for both companies and investors in times of uncertainty. Nasdaq continues to perform a crucial role as a vibrant growth engine for northern European capital markets,” said Roland Chai, President of European Market Services, Nasdaq.

Nasdaq celebrated its 130^th switch from Nasdaq First North Growth Market to Main Market
Despite lower numbers in both capital raised and number of listings relative to previous years, Nasdaq remains the leading European exchange groups in terms of number of SME listings on its markets over the past years. Since the founding of Nasdaq First North in 2006, Nasdaq had its 130^th company to transfer from Nasdaq First North Growth Market to Main Market in December 2023. The 130 companies have grown and matured, presenting an average annual growth rate of 43 percent from the first day of trading on First North to the first day of trading on the Main Market.

“In the midst of economic headwinds, the market has remained challenging in 2023. Despite that Nasdaq has been able to maintain its position as a leading listings venue in Europe, especially for SME companies. Nasdaq First North is the leading SME market not only in terms of bringing companies to the market but also the evolution of companies over time in driving innovation and growth supported by both institutional investors and retail investors. We are pleased to celebrate the 130^th switch from First North to our Main Markets,” said Adam Kostyál, Head of European Listings at Nasdaq.

Continuing to enable sustainable growth
The Nordic and Baltic Sustainable Debt Markets grew by 33% from the previous year to EUR 63 billion (2022: EUR 47.5 bn) during a period of turbulence and relatively low activity in overall Nordic debt market. This is a testament to the ever-growing focus on sustainability amongst investors and companies alike.

Sweden is the most active sustainable bond market in the Nordic and Baltic countries and has historically been dominated by issuers from the real estate sector. In fact, 2023 marks the 10^th anniversary of the worlds’ first green corporate bond, which was issued by the Swedish real estate company Vasakronan. In 2023, new sustainable bond listings grew by 39% in Stockholm, which clearly shows how the concept of green bonds has become an integral part of the broader bond market and that the sustainable bond market is more resilient than ever before.

“It is pleasing to see that our Nordic and Baltic markets remain focused on channeling capital towards sustainable projects and assets also in time of uncertain market. The Nordic and Baltic sustainable bond market is well positioned to grow even faster in coming years when interest rate levels are expected to taper off. We look forward to seeing how the market responds to the new macro environment,” said Fredrik Ekström, President of Nasdaq Stockholm and Head of European Fixed Income.

In October 2023, Nasdaq launched Custom Basket Forwards. The Custom Basket Forwards solution meets the increasing market demand for a simpler and more efficient way of handling equity exposures by utilizing standardized contracts on the regulated market. Custom Basket Forwards enable investors to create a Forward contract on a customized equity basket that is defined by return type, currency, and selected from a European universe of equities, totaling around 1,700+ stocks from 15 countries.

For more details and milestones on Nasdaq’s European market operations in 2023, please see below.

About Nasdaq:
Nasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.

Nasdaq Media Contact
Maarit Bystedt
tel. +358 9 6166 7274
maarit.bystedt@nasdaq.com

SELECTED 2023 EUROPEAN HIGHLIGHTS
LISTINGS

• Nasdaq welcomed 33 new equity listings (among them 7 initial public offerings), raising a total of EUR 431 million. Furthermore, 10 companies switched from Nasdaq First North Growth Market to Nasdaq Main Market. A total of 1,218 companies are currently listed at Nasdaq in Europe of which 687 on Main Market and 531 on Nasdaq First North Growth Market.
• Market by market, Nasdaq Stockholm had 19 listings, Nasdaq Iceland 5 listings, Nasdaq Copenhagen 3 listings, Nasdaq Helsinki 3 listings, Nasdaq Tallinn 2 listings and Nasdaq Riga 1 listing.

TRADING

• Nasdaq saw trading volumes decrease in 2023, with share trading decreasing by 17% to a daily average of EUR 2.9 billion (2022: 3.6 bn) across all markets.
• Nasdaq maintained a market share of 71% (2022: 71%) of lit and auction trading in its listed shares, while continuing to reinforce its leadership in the Nordic derivatives market, including Norway, where Nasdaq has a achieved a 82% market share in single stock options.

SUSTAINABILITY

• The Nordic & Baltic sustainable debt markets grew to EUR 63 billion by the end of 2023 (2022: EUR 47.5 bn).
• Nasdaq majority-owned Puro.earth, the world’s leading crediting platform for engineered carbon removal, issued 128,301 CORCs with durability of more than 100 years. Since Puro.earth was founded in 2019, its supplier partners have durably removed nearly half a million metric tons of CO2 from the atmosphere.

PRODUCTS & PARTNERSHIPS

• Nasdaq Clearing is about to open up for clearing of Interest Rate Swaps (IRS) in EUR, DKK and NOK, in addition to the existing clearing of IRS in SEK. Furthermore, the initiative from the Swedish Central Bank (Riksbanken) offering central clearing parties deposit and lending facilities provides resistance to the clearing market.
• Nasdaq has launched Custom Basket Forwards – an innovative derivative product addressing the rising demand for a simpler and more efficient way of handling tailored equity exposures. Nasdaq Custom Basket Forwards offer a cost-efficient alternative, combining bespoke elements with the benefits of central counterparty clearing and trading on a regulated market. With the launch of Custom Baskets Forwards more clients are given access to a simple and efficient solution for ex. ESG & climate investments, thematic investing, ETF replications, tailor-made indexes, and equity financing.
• In November, Nasdaq launched a pioneering new technology that securely digitizes the issuance, settlement, and custody of carbon credits. It will be provided to market infrastructures, registry platforms, and other service providers globally. Alongside the launch of the service, Nasdaq announced a new technology partnership with Nasdaq majority-owned Puro.earth, a world-leading standards and registry platform for engineered carbon removal, to register CO2 Removal Certificates, or CORCs. The registry tracks the issuance, retirement, and the transfer of the assets, providing full traceability and transparency to avoid double counting carbon removal projects.

RETAIL ENGAGEMENT

• Nasdaq’s role as an exchange is to promote public markets and help educate investors of all sizes, which we do through our financial literacy initiative. Together with more than 20 partnerships and organizations we seek to promote our common purpose of financial progress for all. In 2023, we have driven more than 70 events with our partner organizations and educated thousands of investors across our asset class portfolio.
• Nasdaq Derivatives Academy was launched in the Nordics to increase knowledge of equity derivatives and since its start more than 2,800 private investors and 200 professionals have signed up for the program. In November 2023, the education program was expanded to include Nasdaq Clearing Essentials which is specifically dedicated to professionals working in back-office roles.

NDAQG

GlobeNewswire Distribution ID 9013962

Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva

Colobreathe® is an inhaled antibiotic for the management of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients

The acquisition will help ensure continued access to an important medicine for this vulnerable patient population

First rare disease medicine to be added to the Essential Pharma product portfolio

Zug, Switzerland and Egham, UK – 8 January 2024 – Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically well-established pharmaceutical products across key therapeutic areas, announces that it has completed the acquisition of European rights to Colobreathe® from Teva Laboratories UK Limited.

Colobreathe® is indicated for the management of chronic pulmonary infections due to Pseudomonas aeruginosa (PsA) in patients with cystic fibrosis aged 6 years and older. Bacterial lung infection with PsA is frequent in cystic fibrosis patients due to the accumulation of mucus in the lungs which allows bacteria to grow more easily causing infections, lung damage and breathing problems.¹ There are two elements to Colobreathe®, a capsule containing the active pharmaceutical ingredient and a Turbospin inhaler to deliver the drug.

Under the terms of the acquisition, Essential Pharma has acquired the rights to Colobreathe® across European markets; the product is currently marketed across more than 20 countries in Europe, including the UK. The acquisition represents the first rare disease product acquisition for the group and further establishes Essential Pharma as a leading specialty pharma business ensuring the continual supply of niche medicines of high clinical importance to patients, healthcare providers and carers.

Emma Johnson, CEO of Essential Pharma, commented: “Our singular focus is on ensuring patients can maintain sustainable access to vital medicines. Colobreathe® is an important treatment for a serious complication that arises frequently among cystic fibrosis patients. Our acquisition of the European rights to this medicine, which will become our first product indicated for treatment in a rare disease, will help ensure that cystic fibrosis patients in Europe have continued access.”

About Essential Pharma

Essential Pharma is an international specialty pharmaceutical group dedicated to maintaining access to well-established, at-risk products essential to patients across multiple therapeutic areas. The group has been an important and valued partner to healthcare providers for over 20 years by giving patients access to medicines that otherwise might not be available. Essential Pharma operates globally in more than 70 countries, supplying a portfolio of over 300 products across multiple therapeutic areas. Essential Pharma’s growth strategy is based on identifying and acquiring mature, at-risk products from larger pharmaceutical groups looking to streamline their product portfolios. It is a trusted partner to multiple pharma companies of all sizes, with a proven history of integrating assets and managing complex technology transfers seamlessly while ensuring continuous and sustainable supply to patients.

Essential Pharma’s growth strategy is backed by Gyrus Capital, an investment firm dedicated to transformational investments in sectors with long-term sustainable growth, including healthcare.

For more information, please visit essentialpharmagroup.com

CONTACTS

Essential Pharma

Emma Johnson, CEO

Tel: +44(0)1784 477 167

Email: info@essentialpharmaceuticals.com

ICR Consilium

Mary-Jane Elliott/Tracy Cheung/Chris Welsh

Tel: +44 (0) 20 3709 5700

Email: Essentialpharma@consilium-comms.com

Job code: EP/Consilium/2023/12/001

January 2024

---

¹ https://www.ema.europa.eu/en/documents/overview/colobreathe-epar-summary-public_en.pdf

GlobeNewswire Distribution ID 1000907559